Towards Healthcare
Pneumonia Testing Market Size Attains USD 2.11 Billion in 2025

Pneumonia Testing Market Insights 2025: Tulane’s CRISPR Breakthrough and Lunit AI Imaging Drive Diagnostic Innovation

Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the market. The availability of a robust healthcare infrastructure and favorable reimbursement policies contribute to North America’s dominance. 

Content

  • Insight Code: 5834
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The pneumonia testing market is projected to reach USD 3.85 billion by 2034, growing at a CAGR of 6.97% from 2025 to 2034.

North America is leading the pneumonia testing market due to the availability of a robust healthcare infrastructure, technological advancements, and favorable reimbursement policies.

The pneumonia testing market includes six segments such as test type, by pathogen type, by technology, by end-user, by age group, and by region.

Some key players include F. Hoffmann-La Roche Ltd., Qiagen, and Siemens Healthineers.

Key trends include the rising prevalence of pneumonia, growing research and development activities, and the growing demand for point-of-care diagnostics.

The different types of pneumonia are community-acquired pneumonia, hospital-acquired pneumonia, healthcare-associated pneumonia, ventilator-associated pneumonia, and aspiration pneumonia.

High fever, cough with yellow, green, or bloody mucus, fatigue, shortness of breath, rapid heart rate, and loss of appetite are some of the common symptoms of pneumonia.

UNICEF, Centers for Disease Control and Prevention, Government of Canada, VDGH.de
Any Questions